day 1 agenda

Mon , Sep 09, 2019

  • 07:30
  • Registrations

  • 07:45
  • Opening ceremony & Welcome speech

  • 08:15
  • Keynote Talk-1

    Title: Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol
    Julian Kenyon, Medical Director of The Dove Clinic, UK

  • 08:45
  • Keynote talk-2

    Title: Targeting the HTLV-1-regulated BATF3/IRF4 transcriptional network in adult T-cell leukemia/lymphoma
    Thomas Waldmann, NIH Distinguished Investigator, National Institutes of Health, USA

  • 09:15
  • Keynote talk-3

    Title: Data Integration Innovations to Enhance Analytic Utility of Clinical Trial Content to Inform Health Disparities Research
    Steven B. Cohen, Vice President, RTI International, USA

  • 09:45
  • Keynote Talk-4

    Title: Molecular/Genomic Tests to Guide Precision Cancer Medicine
    Dongfeng Tan, University of Texas MD Anderson Cancer Center, USA

  • 10:15
  • Coffee Break

  • 10:30 to 13:10
  • Scientific Session 1

    Title: Targeting Breast Cancer Stem Cells with FDA approved antibiotics
    Antonio Giuseppe Naccarato, University of Pisa, Italy

    Title: BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers
    Mamoru Takada, Chiba University, Japan

    Title: Artificial Neural Network Algorithms For Biomarker Discovery and Pathway Modelling in Cancer 
    Graham Ball, Nottingham Trent University, UK

    Title: STUM-MRMI-Studies of Tumor Microenvironment by using Magnetic Resonance Molecular Imaging 
    RenHua Wu, Shantou University Medical College, China

    Title: Systemic inflammation score predicts survival in patients with intrahepatic
    Qing Chen, Fudan University, China

    Title: Cancer Metastasis of 118 Kinds of Solid Tumors via Cytocapsular Tubes and Networks
    Tingfang Yi, Cytocapsula Research Institute, USA

    Title: Differential distribution and enrichment of non-coding RNAs in exosomes from Normal and Cancer-Associated Fibroblasts in colorectal cancer
    Cristina Pena, Hospital Universitario Ramón y Cajal, Spain

    Title: An Efficient Cancer-Related Gene Panel for Early-Stage Lung
    Xuesi Dong, Southeast University, China

  • 13:10 to 14:00
  • Lunch Break @ Restaurant

  • 14:00 to 16:10
  • Scientific Session 2

    Title: Classification of gastric carcinomas based upon the cell of origin and physiological knowledge
    Helge L. Waldum, Norwegian University of Science and Technology, Norway

    Title: Usefulness of multi‑parametric MRI for diagnosis of invasive urothelial cancer: Case reports of the bladder and ureteral cancer
    Senji Hoshi, Yamagata Prefectural Central Hospital, Japan

    Speaker slot Available

    Title: Frequency of Human Papilloma Virus infection in Oral Squamous Cell Carcinoma and its clinical significance –A retrospective study
    Divya Raj, Regional Cancer Centre, Trivandrum, India

    Speaker slot Available

    Title: Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients
    Jun Xia, Wuxi People’s Hospital, China

     

  • 16:10 to 16:25
  • Coffee Break

  • 16:25 to 18:05
  • Scientific Session 3

    Title: Novel Combination of Immunotherapy and Vaccine in HPV-Associated Oropharyngeal Cancer
    Erminia Massarelli, Associate Clinical Professor, City of Hope Cancer Center, USA

    Title: B7-H5/CD28H: A new promising immunotherapy target in pancreatic ductal adenocarcinoma
    Qi Chen, The first affiliated hospital of Zhejiang University, China

    Speaker slot Available

    Speaker slot Available

    Speaker slot Available

  • 18:05
  • Panel Discussions

    This is a tentative Scientific Program and subject to change

day 2 agenda

Tue , Sep 10, 2019

  • 08:30
  • Keynote Talk-1

    Title: Hormonal Pathology of the Endometrium and Endometrial Neoplasia
    Liane Deligdisch, Mount Sinai Icahn School of Medicine, USA

  • 09:00
  • Keynote talk-2

    Title: Lighting the path to cancer detection and therapy
    Samuel Achilefu, Washington University School of Medicine, USA

  • 09:30
  • Keynote talk-3

    Title: Plasmonic Nanoprobes: A New Generation of Nanoplatforms for Early Detection and Immunotherapy of Cancer
    Tuan Vo-Dinh, Fitzpatrick Institute for Photonics, Duke University, USA

  • 10:00 to 11:00
  • Scientific Session 1

    Title: Anticancer effects of Combination of Biochanin A & Statins on Glioblastoma Multiforme and Pancreatic Cancer Cells
    Alok Bhushan, Jefferson College of Pharmacy, USA

    Title: Evolutionary and dynamic personalized precision medicine for cancer therapy
    Fengzhi Li, Roswell Park Comprehensive Cancer Center, USA

    Title: Toward the Discovery of a Novel Class of YAP⁻TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP⁻TEAD Protein-Protein Interface
    Philippe Cotelle, University of Lille, UK

  • 11:00
  • Coffee Break

  • 11:15 to 13:15
  • Scientific Session 2

    Title: Zinc metallochaperones: a new class of small molecule mutant p53 reactivators: Restoring binding to zinc deficient mutant p53
    Darren R. Carpizo, Rutgers Cancer Institute of New Jersey, USA 

    Title: Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells
    Pin Ju Chueh, National Chung Hsing University, Taiwan 

    Title: Beneficial effect of additional treatment with widely available anticancer agents in advanced small lung cell carcinoma
    Piotr Kruk, Gminny Osrodek Zdrowia w Rzasni, Poland

    Title: Targeting the extracellular matrix/cancer cell interface to overcome BRAF inhibition resistance in melanoma
    Barbara Bedogni, University of Miami, USA 

    Title: New Therapeutic Targets in Sarcoma
    Anthony Elias, University of Colorado School of Medicine, USA 

    Title: Dosimetry and Treatment Descriptions Using the First Completely Automated Stereotactic Intracranial Radiosurgery Rotating Gamma Ray Unit in America
    Fidel Campos, Centro Internacional de Cancer, El Salvador

  • 13:15 to 14: 00
  • Lunch Break @ Restaurant

  • 14:00 to 14:40
  • Poster Presentations

  • 14:40 to 16:00
  • Scientific Session 3

    Title: Extrinsic and Intrinsic Barriers to Multimodal Therapy in Glioblastoma
    Ahmad Daher, Hartford HealthCare Medical Group, USA 

    Title: Continuous Valganciclovir Treatment Results in Prolonged Survival in Glioblastoma patients
    Afsar Rahbar, Karolinska Institutet, Sweden 

    Title: Therapeutic efficacy of hyperthermia in in vitro and in vivo models of melanoma and colon carcinoma
    Theodora Mantso, Northumbria University, UK

    Speaker slot Available 

    Speaker slot Available 

  • 16:00
  • Coffee Break

  • 16:15 to 17:55
  • Scientific Sessions 4

    Title: Multiple Breath-hold Volumetric Modulated Arc Therapy Under Fluoroscopic Image Guidance with an Embedded Fiducial Marker
    Tsuyoshi Takanaka, Kouseiren Takaoka Hospital, Takaoka, Japan 

    Title: The relationship between GDP per capita and cancer incidence with a special focus on lung
    Tommaso Luzzati, Università di Pisa, Italy

    Title: Radiation-Induced Metabolic Alteration in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications
    Kshama Gupta, Mayo Clinic, Rochester, USA

    Speaker slot Available

    Speaker slot Available

  • 17:55
  • Panel Discussions

day 3 agenda

Wed , Sep 11, 2019

  • 09:00 to 10:25
  • Scientific Session 1

    Title: Real-Time Molecular Diagnosis of Sarcomas Using Water-Assisted Laser Desorption/Ionization Mass Spectrometry Technology
    Yves-Marie ROBIN, CENTRE OSCAR LAMBRET, France 

    Title: Extraskeletal Osteosarcoma Recognized Following Acute Traumatic Injury
    Karleigh Curfman, Duke LifePoint Conemaugh Memorial Medical Center, USA

    Title: The potential of developing inhalable dual drugs formulation (curcumin and paclitaxel) for lung cancer treatment  
    Wing Hin Lee, University of Kuala Lumpur, Malaysia

    Speaker slot Available

  • 10:25
  • Coffee Break

  • 10:40 to 13:00
  • Scientific Session 2

    Title: 18F-Fluoro-2-Deoxy-Glucose Positron Emission-Computed Tomography in a Rare Cutaneous Form Of Rosai Dorfman Disease
    Feras Chehade, Mount Lebanon Hospital, Lebanon 

    Title: Oral cancer Screening -15 years’ experience from India
    K.Ramadas, Regional Cancer Centre, Trivandrum, India 

    Title: Carboxypeptidase E transmits its anti-migratory function in glioma cells via transcriptional regulation of cell architecture and motility regulating factors as well as by changing metabolism
    Ulrike Naumann, University of Tübingen, Germany 

    Title: Development of an Oncologist- Driven Integrative Intervention for Symptom Management in an Academic Cancer Center
    Lanie Francis, University of Pittsburgh Medical Center, USA

    Title: IL-17A Promotes the Invasion-metastasis Cascade via the AKT Pathway in Hepatocellular Carcinoma
    Fang-Ming Gu, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, China

    Title: Development and validation of a prognostic nomogram for extremity soft tissue leiomyosarcoma
    MingFeng Xue, The Second Hospital of Jiaxing, The Second Affiliated Hospital of Jiaxing University, China

    Title: A novel strategy to cure cancer
    Adnan Yousif Rojeab, The London College UCK, UK

  • 13:00 to 14:00
  • Lunch Break @ Restaurant

  • 14:00 to 16: 00
  • Scientific Sessions 3

    Speaker slot Available

    Speaker slot Available

    Speaker slot Available

    Speaker slot Available

    Speaker slot Available

     

  • 16:00
  • Coffee Break

  • Panel Discussions

  • Thanks giving & Closing ceremony

  • NOTE:

    This is a tentative program only and Program Schedule is subject to change with the final allotment of speaker slots.

    We are pleased to inform you that we have only a few speaker slots left if you are interested Please contact Dr. James Angel at cancercongress@innovincinternational.com

    Looking forward to welcoming to you the World’s largest City London, UK.

     

posters agenda

Tue , Sep 10, 2019

  • 14:00 to 14:40
  • Poster Presentations

    Title: A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: Evaluation of efficacy, safety, and patient-reported 
    Kosei Kimura, Osaka Medical College Hospital, Japan

    Title: A treatment field margin formula for stereotactic radiotherapy
    Kiyoshi Yoda, Elekta KK, Japan

    Title: Anastomotic Leak after Esophagectomy for Esophageal Cancer Treated with a Stent: A Case Report 
    Rasha Saeed, Riverside community hospital, USA

    Poster presentation slot Available

    Poster presentation slot Available

    Poster presentation slot Available

    Poster presentation slot Available

    Poster presentation slot Available

Conference Agenda Download